Fibrinogen and fibrinogen-fibrin degradation products in experimental African trypanosomiasis.
D000818:Animals; D001152:Arsenicals / Q000627:therapeutic use; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D005337:Fibrin / Q000032:analysis*; D005340:Fibrinogen / Q000032:analysis*; D005341:Fibrinolysin / Q000037:antagonists & inhibitors; D006386:Hemagglutination Tests; D007114:Immunization; D008297:Male; D010958:Plasminogen / Q000032:analysis; D011817:Rabbits; D012756:Sheep / Q000276:immunology; D013917:Thrombin / Q000494:pharmacology; D013997:Time Factors; D014227:Triazines / Q000627:therapeutic use; D014344:Trypanocidal Agents / Q000627:therapeutic use; D014353:Trypanosomiasis, African / Q000097:blood* / Q000188:drug therapy
D001152:Arsenicals; D014227:Triazines; D014344:Trypanocidal Agents; D005337:Fibrin; D005340:Fibrinogen; D010958:Plasminogen; D013917:Thrombin; D005341:Fibrinolysin